Surgical Strategy for Recurrent Giant Cell Tumor in the Thoracolumbar Spine.

TES with wide/marginal margin should be offered to patients with RGCT whenever feasible, given its long-term benefits in local control and symptom alleviation. Additionally, patients with lower Ki67 index and application of denosumab tend to have a better prognosis.